Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry.
Miller PD, Bonnick SL, Rosen CJ, Altman RD, Avioli LV, Dequeker J, Felsenberg D, Genant HK, Gennari C, Harper KD, Hodsman AB, Kleerekoper M, Mautalen CA, McClung MR, Meunier PJ, Nelson DA, Peel NF, Raisz LG, Recker RR, Utian WH, Wasnich RD, Watts NB. Miller PD, et al. Among authors: harper kd. Semin Arthritis Rheum. 1996 Jun;25(6):361-72. doi: 10.1016/s0049-0172(96)80001-1. Semin Arthritis Rheum. 1996. PMID: 8792508 Review.
Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial.
Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, Reginster JY, Pols HA, Recker RR, Harris ST, Wu W, Genant HK, Black DM, Eastell R; Mulitple Outcomes of Raloxifene Evaluation Investigators. Delmas PD, et al. Among authors: harper kd. J Clin Endocrinol Metab. 2002 Aug;87(8):3609-17. doi: 10.1210/jcem.87.8.8750. J Clin Endocrinol Metab. 2002. PMID: 12161484 Clinical Trial.
The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study.
Silverman SL, Minshall ME, Shen W, Harper KD, Xie S; Health-Related Quality of Life Subgroup of the Multiple Outcomes of Raloxifene Evaluation Study. Silverman SL, et al. Among authors: harper kd. Arthritis Rheum. 2001 Nov;44(11):2611-9. doi: 10.1002/1529-0131(200111)44:11<2611::aid-art441>3.0.co;2-n. Arthritis Rheum. 2001. PMID: 11710717 Free article.
Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials.
Johnston CC Jr, Bjarnason NH, Cohen FJ, Shah A, Lindsay R, Mitlak BH, Huster W, Draper MW, Harper KD, Heath H 3rd, Gennari C, Christiansen C, Arnaud CD, Delmas PD. Johnston CC Jr, et al. Among authors: harper kd. Arch Intern Med. 2000 Dec 11-25;160(22):3444-50. doi: 10.1001/archinte.160.22.3444. Arch Intern Med. 2000. PMID: 11112238 Clinical Trial.
Severe osteoporosis in men.
Kelepouris N, Harper KD, Gannon F, Kaplan FS, Haddad JG. Kelepouris N, et al. Among authors: harper kd. Ann Intern Med. 1995 Sep 15;123(6):452-60. doi: 10.7326/0003-4819-123-6-199509150-00010. Ann Intern Med. 1995. PMID: 7639446 Review.
Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes.
Barrett-Connor E, Ensrud KE, Harper K, Mason TM, Sashegyi A, Krueger KA, Anderson PW. Barrett-Connor E, et al. Clin Ther. 2003 Mar;25(3):919-30. doi: 10.1016/s0149-2918(03)80114-5. Clin Ther. 2003. PMID: 12852708 Clinical Trial.
60 results